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Abstract: Fungal maleidrides are an important family of
bioactive secondary metabolites that consist of 7, 8, or 9-
membered carbocycles with one or two fused maleic anhydride
moieties. The biosynthesis of byssochlamic acid (a nonadride)
and agnestadride A (a heptadride) was investigated through
gene disruption and heterologous expression experiments. The
results reveal that the precursors for cyclization are formed by
an iterative highly reducing fungal polyketide synthase sup-
ported by a hydrolase, together with two citrate-processing
enzymes. The enigmatic ring formation is catalyzed by two
proteins with homology to ketosteroid isomerases, and assisted
by two proteins with homology to phosphatidylethanolamine-
binding proteins.
Maleidrides are bioactive medium-ring carbocyclic com-
pounds with one or two maleic anhydride moieties and are
produced by fungi. Byssochlamic acid (1; Figure 1), discov-
ered by Raistrick and Smith in the 1930s,[1] was one of the first
maleidrides to have its structure elucidated in the 1960s.[2–4]
The structures of its isomers glaucanic acid (2)[3] and
heveadride (3)[5] were also solved at that time. More recent
examples include phomoidride A (4, an inhibitor of squalene
synthase and Ras farnesyl transferase),[6] rubratoxins such as 5
(recently shown to suppress cancer metastasis),[7] cornexistin
(6, which shows potent and selective herbicidal activity),[8]
and zopfiellin (7).[9]Heptadrides are also known, for example,
agnestadride A (8), which was isolated along with byssochla-
mic acid (1) from Byssochlamys fulva.[10] In 1965, Barton and Sutherland proposed a scheme for the
biosynthesis of 1, 2, and 3.[3] They envisaged biosynthesis from
the C9-maleic anhydride monomer 9, with the differences in
the position of the substituents explained by either “head-to-
tail” or “head-to-head” dimerization. However the molecular
basis for this dimerization has remained unknown until now.
A reinvestigation of the metabolites produced by B. fulva
led to the identification of the probable monomer 10, which
undergoes facile decarboxylation to 9. Decarboxylation is
also proposed to produce the exo-methylene putative inter-
mediate 11 (Scheme 1),[10] which can then undergo cyclization
with a second molecule of 10 to produce 1. Another mode of
dimerization of 10 (head-to-side dimerization) explains the
biosynthesis of agnestadride A (8).[10]
Barton and Sutherland also hypothesized that monomer 9
is a modified product of the citric acid cycle, produced from
a polyketide-derived hexanoate with oxaloacetate.[3] Isotopic
feeding studies supported this hypothesis[11] and suggested
that a candidate maleidride biosynthetic gene cluster (BGC)
should contain a highly reducing polyketide synthase
(hrPKS),[12] as well as a gene encoding a citrate-synthase-
like enzyme.[13]
Figure 1. Examples of maleidrides and the hypothesized precursor.
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Based on this hypothesis, we sequenced the genomes of
two B. fulva strains, IMI 40021 and IMI 58422, both of which
are linked to the original strain investigated by Raistrick and
Smith.[1] The former reliably produces byssochlamic acid, but
the latter is an unreliable and generally poor producer.
BLAST[14] analyses were utilized to search the genomes of
both B. fulva strains for likely maleidride BGCs, which led to
the identification of a highly homologous maleidride-type
BGC in each genome (Figure 2, Genbank accession
KU928136). Each BGC contains an hrPKS, a citrate-syn-
thase-like enzyme, and several other interesting genes,
including a methylcitrate dehydratase. Transcriptomic analy-
sis of B. fulva IMI 40021 under byssochlamic acid producing
and non-producing conditions confirmed that the putative
BGC is highly differentially expressed (Figure 2). The two
BGCs are more than 97% identical but show differences in
the bfR4 promoter region, which might explain the low
productivity we observed in the IMI 58422 strain (see the
Supporting Information).
BLAST[14] searches of genome sequences deposited at the
NCBI, utilizing bfpks1 and the citrate synthase-like gene
(bfL2) as queries, revealed several further likely maleidride
BGCs in different fungi. Two BGCs were identified from
Talaromyces stipitatus. Many Talaromyces species are known
to produce glaucanic acid (2), as well as the more complex
rubratoxin B (5).[15] A third BGC was identified in a Cochlio-
bolus species. Cochliobolus species are synonymous with
Helminthosporium, which are the
original producers of heveadride
(3).[5, 16]
The bfpks1 gene that encodes
the PKS was knocked out by
using the bipartite method[17] to
produce B. fulva bfDpks1 strains,
which no longer produced bysso-
chlamic acid (1) or agnestadri-
de A (8 ; Figure 3A and 3B). This
is consistent with heptadride 8
being formed from the same path-
way as byssochlamic acid.
In a recent investigation of the
biosynthesis of phomoidride A
(4), Oikawa and co-workers also
identified a BGC containing an
hrPKS, a citrate-synthase-like
enzyme, and a methylcitrate
dehydratase, as well as the two
maleidride-type BGCs from
Talaromyces stipitatus.[18]Heterol-
ogous expression experiments uti-
lizing the three genes from one of
the T. stipitatus BGCs allowed the
isolation of a longer-chain decar-
boxylated monomer. These
experiments confirm the poly-
ketide/oxaloacetate origin of mal-
eidride monomers.[18] However
the proteins responsible for the
key cyclisation reaction necessary
for maleidride biosynthesis remain unkown.
From comparison of the two B. fulva BGCs and the other
BGCs identified above, four highly conserved genes were
chosen for heterologous expression experiments in Aspergil-
lus oryzae NSAR1:[19,20] the hrPKS bfpks1; the citrate-
synthase-like gene bfL2 ; the methylcitrate dehydratase
bfL3 ; and the hydrolase 341 bfL1, which encodes a protein
homologous to Type II thiolesterases such as RifR,[21] which
are involved in the release of abberant ACP-bound poly-
ketide intermediates during modular polyketide biosynthesis,
as well as to LovG, which releases the lovastatin nonaketide
from its PKS.[22]
Expression of these four core genes in A. oryzae NSAR1
(strains AO-BF-PMCH 1–7) led to the production of both 9
and 10 (Figure 3D). Compound 9 is already known to be the
decarboxylation product of the highly volatile and unstable
10.[10] We also expressed bfpks1, bfL2, and bfL3 in the
absence of bfL1, which encodes the hydrolase. Under these
conditions, 9 and 10 were not produced (see the Supporting
Information), thus strongly suggesting that the hydrolase is
essential in the byssochlamic acid system.
Oikawa and co-workers suggested that the longer-chain
decarboxylated monomer isolated from their heterologous
expression experiments is produced by an adventitious native
decarboxylase.[18] Our experiments have previously identified
the natural product 10 by comparing its LCMS characteristics
with data collected for the synthetic homologue, which was
Scheme 1. Proposed general pathway to maleidrides.
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also observed to decarboxylate spontaneously to give 9. This
demonstrates that, at least for the shorter-chain maleic
anhydrides, no enzymatic decarboxylation is necessary.[10]
To investigate the dimerization process, several further
genes were selected for heterologous expression. Analysis of
the BGC comparisons from several organisms (Figure 2)
revealed that in addition to the core genes, two further types
of genes are common to each BGC, namely either one or two
genes encoding putative ketosteroid isomerase (KI)-like
proteins and either one or two putative phosphatidylethanol-
amine-binding proteins (PEBP).
Co-expression of the two KI-like genes (bfL6 and bfL10)
with the core genes (bfpks1, bfL1, bfL2, and bfL3) in the
heterologous host (strains AO-BF-PMCH+KIs 1–21) led to
the production of byssochlamic acid (1) and the decarboxy-
lated intermediate 9 in several transformants (Figure 3E).
Agnestadride A (8) and the intermediate 10 were also
detected, but in low titer (see the Supporting Information).
This result shows that in the A. oryzae NSAR1 background,
the four core “monomer” genes and the KI-like genes are
sufficient to form both nonadrides and heptadrides.
To determine whether the presence of both KI-like genes
is necessary for dimerization, or alternatively, whether each
KI-like gene controls a different dimerization mode (nona-
dride/ heptadride), the core “monomer” genes were co-
expressed with either KI1 (bfL6) or KI2 (bfL10) alone to give
strains AO-BF-PMCH+KI1 1–7 and AO-BF-PMCH+KI2
1–7. Both sets of strains only produced 9 and 10, with no
evidence for dimerized products (see the Supporting Infor-
mation). Reverse-transcription PCR (RT-PCR) confirmed
that both KI1 and KI2 genes were expressed in each
experiment, therefore it can be concluded that within the A.
oryzae NSAR1 background, the core “monomer” genes and
KI1 or KI2 alone are not sufficient to catalyze dimerization.
The BGC comparisons also revealed that genes encoding
proteins similar to PEBPs are common to all of the maleidride
BGCs (Figure 2). The two PEBP genes (bfL5 and bfL9) were
Figure 2. Top: transcriptome analysis of the byssochlamic acid (1)
biosynthetic gene cluster in B. fulva IMI 40021 under producing
(green) and non-producing (black) conditions. Bottom: comparative
genomic analysis of other putative maleidride BGCs.
Figure 3. HPLC (DAD, 210–600 nm) chromatograms. A) Extract from
WT B. fulva ; B) extract from B. fulva Dpks1; C) extract from untrans-
formed A. oryzae NSAR1; D) extract from A. oryzae transformant BF-
PMCH; E) extract from A. oryzae transformant BF-PMCH+KIs;
F) extract from A. oryzae transformant BF-PMCH+KIs+PEBPs;
G) Purified agnestadride A (8); H) Purified byssochlamic acid (1).
Compounds 12, 12’, and 13 are cometabolites of 1 and have been
previously identified and characterized.[10]
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thus co-expressed with the core genes and the KI-like genes in
A. oryzae NSAR1 to create strains AO-BF-PMCH+KIs+
PEBPs 1–8. No new compounds were identified from extracts
from these strains. However, direct quantitative comparisons
between strains containing the PEBP genes in addition to KI
genes showed an over 20-fold increase in the biosynthesis of
byssochlamic acid (to 44 mgL¢1, Figure 3F), as well as
a corresponding increase in the production of the heptadride
8. Byssochlamic acid (1) isolated from these experiments was
chromatographically and spectroscopically identical to 1 iso-
lated from wild-type (WT) B. fulva (see the Supporting
Information). Compounds 12 and 12’ were also observed in
these experiments: these are most likely formed in vitro
through partial hydrolysis of 1 during extraction and analysis.
However, the reduction product 13 is not formed inA. oryzae,
thus suggesting that 13 arises inB. fulva through the activity of
an adventitious enzyme.
The biosynthetic pathway to byssochlamic acid and
agnestadride A has thus been fully elucidated through
genome and transcriptome sequencing, gene disruption, and
heterologous expression. Putative maleidride BGCs were
identified from the genomes of Talaromyces and Cochliobo-
lus species. Both genera are known to produce nonadrides.
Comparison of the byssochlamic acid cluster to the putative
maleidride gene clusters identified a core set of genes that are
common to all five BGCs. Four genes were identified (bfpks1,
bfL1, bfL2, and bfL3) that, when expressed in the heterol-
ogous host A. oryzae NSAR1, produce the monomer 10, as
well as its spontaneous decarboxylation product 9, both of
which have been previously identified from WT B. fulva
extracts.[10] Experiments to determine the genes involved in
dimerization demonstrated that both KI-like genes co-
expressed with the core genes are necessary. Furthermore,
co-expression of the core genes with both KI-like genes and
both PEBPs gave increased yields of dimerized products. The
mechanism for the dimerization still needs to be established
through in vitro experiments.
Based on previous biosynthetic investigations, our dis-
covery of the byssochlamic acid pathway, and research
conducted by Oikawa and co-workers,[18] we now propose
a general biosynthetic route to maleidrides (Scheme 1). In
each maleidride pathway, the initial steps are common, with
potential differences including polyketide chain length and
pattern of reduction. For example, the biosynthesis of 1–3, 6,
and 8 requires triketides; 5 requires pentaketides; and 4
requires hexaketides. The polyketide is presumably released
from the PKS by the BfL1 hydrolase, although it is not yet
known whether this is as the free acid or as a CoA-thiolester.
This result contrasts with the recently reported work of
Oikawa, who showed that the hydrolase did not appear to be
required in the case of a Talaromyces PKS.[18] However it is
known that some iterative fungal PKSs, for example the
squalestatin tetraketide synthase,[23] can release polyketides
without the requirement for a dedicated thiolesterase.
Reaction between the polyketide and oxaloacetate, catalyzed
by the citrate-synthase-like enzyme, is followed by dehydra-
tion by the methylcitrate dehydratase homologue, which then
sets up the synthesis of the maleic anhydride decarboxylated
monomers 9 and 11. It is interesting to note that fungi have
evolved at least two distinct routes to maleic anhydride
moieties. Other organisms oxidize vicinal aromatic methyl
groups to form this biologically important motif.[24,25]
The KI-like enzyme(s) can then react 10 with either 9 or
11. These differences, and the orientation of the reacting
species, determine the size, substitution pattern, and stereo-
chemistry of the central carbocyclic ring. Previous in vitro
work by Baldwin and others[26] has shown that such reactions
are chemically feasible, although in the absence of enzymes,
strong bases are required and low yields are observed. Our
experiments suggest that the KI-like proteins from B. fulva
act together to form heterodimeric enzymes that show
“flexibility” in that they create both nonadrides and hepta-
drides. To our knowledge, B. fulva IMI 40021 is the first
fungus known to produce cross-class maleidrides (i.e., nona-
dride and heptadride), so this “flexibility” may be specific to
the byssochlamic acid/agnestadride A pathway. Other known
maleidride producers appear to have pathways that only
involve one class of dimerization, although it is possible that
reinvestigation of the metabolites produced may identify
other minor compounds with different dimerization modes.
The PEBP-like enzymes also appear to be involved in the
dimerization, and although their catalytic role is not yet clear,
it is possible their known anionic binding ability may be
involved.[27] One possibility may be the chaperoning of highly
unstable carboxylates such as 10 in order to prevent
premature decarboxylation prior to dimerization. However
further understanding of the role of the KI and PEBP
proteins must await in vitro experiments. Gene clusters
encoding the biosynthesis of octadrides such as zopfiellin
(7) have not yet been reported, but our results suggest that
similar KI-like and PEBP-like proteins may be involved in
their biosynthesis.
In conclusion, our experiments have revealed for the first
time that maleidride biosynthesis can be recreated in
a heterologous host and the observations open the way for
future experiments to create new compounds in this class with
potentially interesting and useful biological properties
through pathway engineering. Further experiments are cur-
rently underway in our laboratories to understand the
mechanisms and selectivity of the ring-forming enzymes.
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